Clinical Trials
4 trialsNCT04265274 2023-10-06
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
National Cancer Institute, Slovakia
Phase 2 Withdrawn
NCT05296577 2023-09-25
Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT01730677 2014-03-12
LV
National Cancer Center, Korea
Phase 2 Unknown
NCT00532623 2011-06-27
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
National Cancer Center, Korea
Phase 2 Completed